Merck & Co., Inc. news

   Watch this stock
Showing stories 1 - 10 of about 157   

Articles published

MRK 57.61 +0.98 (1.73%)
price chart
A Quick Look at Merck & Co. Inc.'s Drug Development Pipeline
Today, I'd suggest we take a closer look at Merck's (NYSE: MRK ) drug development pipeline in order to get a better idea of how well the company is preparing for its future beyond patent expirations, as well as note which handful of developing drugs ...
Related articles »  
Bayer closes acquisition of consumer care business of Merck & Co., Inc. for ...
Bayer has completed the global acquisition of the consumer care business of the U.S. pharmaceuticals group Merck & Co., Inc., Whitehouse Station, New Jersey. The transaction closed on October 1, 2014, following receipt of required antitrust approvals.
Company Update: Merck & Co Inc (NYSE:MRK) - Merck Completes Sale of ...  Jutia Group
Related articles »  
Better Dividend Stock: Merck & Co. Inc. or Bristol-Myers Squibb Co.?
Dividend stocks are arguably the most critical component to the success of any long-term investor. According to the latest statistics from FactSet, S&P 500 companies paid out a whopping $91.5 billion in dividends during the second quarter, or an ...
Related articles »  
Morning Watch List : Merck & Co. Inc. (NYSE:MRK), Cisco Systems, Inc ...
Merck & Co. (NYSE:MRK) will post its Q314 quarterly earnings results on Monday, October 27th. Analysts expect Merck & Co. to post earnings of $0.88 per share and revenue of $10.66 billion for the quarter. Merck & Co. has set its FY14 guidance at ...
Merck & Co. (MRK) Scheduled to Post Earnings on Monday  WKRB News
Stocks in Focus � Halliburton Company, (NYSE:HAL), Merck & Co., (NYSE ...  Techsonian (press release)
Related articles »  
Ragwitek by Merck & Co, Inc, and Catalent Pharma
The FDA has approved sublingual Ragwitek (Short Ragweed Pollen Allergen Extract) tablets as an immunotherapy option for selected patients with confirmed ragweed pollen�induced allergic rhinitis.
Related articles »  
Ex-Merck analyst faces insider trading charges on merger tips
NEW YORK Oct 14 (Reuters) - Federal prosecutors in New York charged a former Merck & Co Inc employee with conspiracy to commit fraud for tipping a contact about potential mergers, including Merck's takeover of Idenix Pharmaceuticals ahead of a public ...
Company Update (NYSE:MRK): Ex-Merck analyst faces insider trading charges ...  Jutia Group
Related articles »  
Merck Still Looks Very Expensive (MRK)
In the case of Merck (NYSE:MRK), earnings growth deteriorated from the second quarter of 2012 and it has been flat lining, so to speak, since then.
Related articles »  
Merck & Co., Inc. Stock Still Holding Its Position As A Big-Pharma Leader
Merck & Co. (NYSE: MRK) is the perfect example of a go-to �safe harbor� stock when market conditions turn bearish, as they did last Thursday and early Monday morning.
Related articles »  
Hot News : Merck & Co. Inc. (NYSE:MRK), Alcoa Inc. (NYSE:AA), Sprint ...
Swiss drug manufacturer Roche and U.S. group Merck & Co., Inc. (NYSE:MRK) are going to present data on their competingimmune-therapy medicines in breast cancer in December, spreading the novel tactic to fighting tumor's to another cancer type.
Investors Buy High Volume of Call Options on Merck & Co. (MRK)  Ticker Report
Related articles »  
Company Update: Merck & Co Inc (NYSE:MRK) - Merck Announces Proposed ...
Merck & Co Inc (NYSE:MRK) [Business Wire] - Merck & Co., Inc. , known as MSD outside the United States and Canada, announced today the commencement of a public offering of three series of Euro denominated senior unsecured notes due 2021, 2026 ...
Merck Announces Proposed Public Debt Offering  Business Wire (press release)
Merck Prices EUR 2.5 Bln Debt Offering  RTT News
Related articles »